Cellares
Facts
- HQ
- San Francisco
- Sectors
- Biotech, Cell therapy, Biomanufacturing, Automation
- Founders
- Fabian Gerlinghaus, Omar Kurdi
Fast-growing biotech startup Cellares plans layoffs after losing major pharmaceutical customer
Biotech startup Cellares is planning layoffs after losing a major pharmaceutical customer, even though it had doubled its client base since early 2026.
Cellares and Kriya Join FDA PreCheck Pilot to Accelerate U.S. Drug Manufacturing Approvals with Trump Administration Support
Two Bay Area companies, Cellares and Kriya, have joined the FDA PreCheck pilot program aimed at accelerating drug manufacturing facility approvals. This initiative is supported by the Trump administration to fast-track drug manufacturing processes across the U.S.
Top Growth Investors in Health Tech Revealed in Guide to Aid Fundraising Amid Market Challenges
This article provides a curated guide to the most active growth-stage investors in health tech, aimed at helping founders and early-stage investors understand who is funding larger rounds despite current market challenges. The list, compiled by an early-stage investor from various top-tier growth funds, will be updated regularly to serve as a practical resource for fundraising and networking in the sector.
